Stock MIRM MIRUM PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Mirum Pharmaceuticals, Inc.

Equities

MIRM

US6047491013

Real-time Estimate Cboe BZX
Other stock markets
 12:37:26 2024-06-05 pm EDT 		5-day change 1st Jan Change
25.92 USD +0.52% Intraday chart for Mirum Pharmaceuticals, Inc. +5.53% -13.45%
May. 31 Mirum Pharmaceuticals Gets Positive Opinion From EU Committee on Marketing Authorization for Livmarli to Treat PFIC MT
May. 31 Mirum Pharmaceuticals Announces Positive Chmp Opinion for Livmarli® (Maralixibat) Oral Solution for the Treatment of Pfic in Patients Three Months of Age and Older CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. MIRM Stock
  4. Revisions Mirum Pharmaceuticals, Inc.